CenterBook Partners LP Purchases 3,239 Shares of Molina Healthcare, Inc $MOH

CenterBook Partners LP increased its position in Molina Healthcare, Inc (NYSE:MOH) by 15.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,648 shares of the company’s stock after acquiring an additional 3,239 shares during the quarter. CenterBook Partners LP’s holdings in Molina Healthcare were worth $4,104,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of MOH. Torren Management LLC bought a new position in shares of Molina Healthcare in the fourth quarter valued at approximately $26,000. Miller Global Investments LLC bought a new position in shares of Molina Healthcare in the fourth quarter valued at approximately $27,000. Cromwell Holdings LLC boosted its position in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after acquiring an additional 125 shares during the period. Rakuten Securities Inc. boosted its position in shares of Molina Healthcare by 5,020.0% in the fourth quarter. Rakuten Securities Inc. now owns 256 shares of the company’s stock valued at $44,000 after acquiring an additional 251 shares during the period. Finally, MUFG Securities EMEA plc bought a new position in shares of Molina Healthcare in the second quarter valued at approximately $48,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Trading Up 3.9%

Shares of Molina Healthcare stock opened at $198.34 on Tuesday. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $311.52. The firm has a market cap of $10.33 billion, a PE ratio of 58.68 and a beta of 0.80. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The company has a 50 day simple moving average of $169.59 and a two-hundred day simple moving average of $162.97.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the previous year, the business posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Analysts expect that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Morgan Stanley raised their price objective on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research report on Thursday. Barclays raised their price objective on shares of Molina Healthcare from $161.00 to $199.00 and gave the company an “underweight” rating in a research report on Tuesday, May 26th. Robert W. Baird raised their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Finally, Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a research report on Wednesday, April 29th. Three research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $182.73.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.